A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2021

Primary Completion Date

April 25, 2022

Study Completion Date

May 19, 2022

Conditions
Chronic Kidney DiseaseDiabetic Kidney Disease
Interventions
DRUG

BAY2327949

60 mg of BAY2327949 (2 tablets of 30 mg, orally) once daily for 28 days.

DRUG

Placebo

Matching placebo orally once daily for 28 days.

Trial Locations (36)

1011

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne

1060

Zentrum f. klinische Studien Dr. Hanusch GmbH, Vienna

1090

Universitätsklinikum AKH Wien, Vienna

1130

Klinik Hietzing, Vienna

2020

Skedsmo Medisinske Senter, Skedsmokorset

2317

AKTIMED Helse AS, Hamar

2326

Sykehuset Innlandet HF Hamar, Hamar

2650

Hvidovre Hospital, Hvidovre

3010

Inselspital Universitätsspital Bern, Bern

3100

Universitätsklinikum St. Pölten, Sankt Pölten

3400

Nordsjællands Hospital, Hillerød

4011

Stavanger Helseforskning AS, Stavanger

4021

Konventhospital Barmherzige Brüder Linz, Linz

6700

Sydvestjysk Sygehus Esbjerg, Esbjerg

6807

Landeskrankenhaus Feldkirch, Feldkirch

7006

St. Olavs Hospital HF, Trondheim

7400

Regionshospitalet Herning, Herning

8036

Medizinische Universität Graz, Graz

8200

Aarhus Universitetshospital, Skejby, Aarhus N

9007

Kantonsspital St. Gallen, Sankt Gallen

15850

Päijät-Hämeen keskussairaala, Lahti

20520

Turun yliopistollinen keskussairaala, kantasairaala, Turku

70100

Health Step Finland Oy, Kuopio

90220

Oulun yliopistollinen sairaala, Oulu

1105 AZ

Academisch Medisch Centrum (AMC), Amsterdam

3318 AT

Albert Schweitzer Ziekenhuis, Locatie Dordwijk, Dordrecht

5600 PD

Maxima Medisch Centrum, locatie Eindhoven, Eindhoven

3331 LZ

Albert Schweitzer Ziekenhuis, locatie Zwijndrecht, Zwijndrecht

0586

Oslo Universitetssykehus HF, Rikshospitalet, Oslo

405 45

Carlanderska Sjukhuset, Gothenburg

222 22

ProbarE, Lund

795 30

Dalecarlia Clinical Research, Rättvik

113 65

Center For Diabetes, Academic Specialist Center, Stockholm

751 85

Akademiska Sjukhuset, Uppsala

DK-5000

Odense Universitetshospital, Odense C

FIN 60220

Seinäjoen keskussairaala, Seinäjoki

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bayer

INDUSTRY